Related references
Note: Only part of the references are listed.Discovery of Bile Acid Derivatives as Potent ACE2 Activators by Virtual Screening and Essential Dynamics
Bianca Fiorillo et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)
Shedding Light on COVID-19: ADAM17 the Missing Link?
Brittany Schreiber et al.
AMERICAN JOURNAL OF THERAPEUTICS (2021)
Biologia Futura: is ADAM 17 the reason for COVID-19 susceptibility in hyperglycemic and diabetic patients?
Ganna Stepanova
BIOLOGIA FUTURA (2021)
UniProt: the universal protein knowledgebase in 2021
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2021)
Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality
Yadira Palacios et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Tunnel engineering for modulating the substrate preference in cytochrome P450BsβHI
Shuaiqi Meng et al.
BIORESOURCES AND BIOPROCESSING (2021)
ADAM17 inhibition may exert a protective effect on COVID-19
Vanesa Palau et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)
Challenges in Matrix Metalloproteinases Inhibition
Helena Laronha et al.
BIOMOLECULES (2020)
Discovery of Novel Small-Molecule Calcium Sensitizers for Cardiac Troponin C: A Combined Virtual and Experimental Screening Approach
William H. Coldren et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
Donato Zipeto et al.
FRONTIERS IN IMMUNOLOGY (2020)
Modeling of Protein-Protein Interactions in Cytokinin Signal Transduction
Dmitry V. Arkhipov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
ADAM17: An Emerging Therapeutic Target for Lung Cancer
Mohamed Saad et al.
CANCERS (2019)
What Contributes to Serotonin-Norepinephrine Reuptake Inhibitors' Dual-Targeting Mechanism? The Key Role of Transmembrane Domain 6 in Human Serotonin and Norepinephrine Transporters Revealed by Molecular Dynamics Simulation
Weiwei Xue et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Enzyme-Polyelectrolyte Complexes Boost the Catalytic Performance of Enzymes
Martin J. Thiele et al.
ACS CATALYSIS (2018)
Considerations on inhibition approaches for proinflammatory functions of ADAM proteases
Daniela Dreymueller et al.
PLATELETS (2017)
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
Marcia L. Moss et al.
MEDIATORS OF INFLAMMATION (2017)
The ClusPro web server for protein-protein docking
Dima Kozakov et al.
NATURE PROTOCOLS (2017)
The shedding protease ADAM17: Physiology and pathophysiology
Friederike Zunke et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
The metalloproteinase ADAM10: A useful therapeutic target?
Sebastian Wetzel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models
Caterina Camodeca et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
ADAMs family and relatives in cardiovascular physiology and pathology
Pu Zhang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate
Franck Madoux et al.
SCIENTIFIC REPORTS (2016)
Extracellular Juxtamembrane Segment of ADAM17 Interacts with Membranes and Is Essential for Its Shedding Activity
Stefan Duesterhoeft et al.
BIOCHEMISTRY (2015)
Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: Discovery and computational modeling of a new series of ligands with nanomolar affinity
Andrew Anighoro et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
James A. Maier et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes
Anna M. Knapinska et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Beware of docking!
Yu-Chian Chen
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Diverse Levels of Sequence Selectivity and Catalytic Efficiency of Protein-Tyrosine Phosphatases
Nicholas G. Selner et al.
BIOCHEMISTRY (2014)
YASARA View-molecular graphics for all devices-from smartphones to workstations
Elmar Krieger et al.
BIOINFORMATICS (2014)
Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space
Jessica Pruessmeyer et al.
BLOOD (2014)
AutoDock4Zn: An Improved Auto Dock Force Field for Small-Molecule Docking to Zinc Metalloproteins
Diogo Santos-Martins et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Development of a 'mouse and human cross-reactive' affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy
Hang Fai Kwok et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2014)
Upregulated Expression of ADAM17 Is a Prognostic Marker for Patients With Gastric Cancer
Zhang-Xuan Shou et al.
ANNALS OF SURGERY (2012)
A practical guide to modelling enzyme-catalysed reactions
Richard Lonsdale et al.
CHEMICAL SOCIETY REVIEWS (2012)
Discovery of Novel Inhibitors of a Disintegrin and Metalloprotease 17 (ADAM17) Using Glycosylated and Non-glycosylated Substrates
Dmitriy Minond et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
PROSPER: An Integrated Feature-Based Tool for Predicting Protease Substrate Cleavage Sites
Jiangning Song et al.
PLOS ONE (2012)
Structural Characterization of Three Novel Hydroxamate-Based Zinc Chelating Inhibitors of the Clostridium botulinum Serotype A Neurotoxin Light Chain Metalloprotease Reveals a Compact Binding Site Resulting from 60/70 Loop Flexibility
Aaron A. Thompson et al.
BIOCHEMISTRY (2011)
2-(2-Aminothiazol-4-yl)pyrrolidine-based tartrate diamides as potent, selective and orally bioavailable TACE inhibitors
Chaoyang Dai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds
Joshua Roth et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
The many faces of the adamantyl group in drug design
Joe Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery
Roman A. Laskowski et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Cross-domain inhibition of TACE ectodomain
Christopher J. Tape et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Discovery and SAR of hydantoin TACE inhibitors
Wensheng Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Biaryl substituted hydantoin compounds as TACE inhibitors
Wensheng Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Structure and activity relationships of tartrate-based TACE inhibitors
Dansu Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
The discovery of novel tartrate-based TNF-α converting enzyme (TACE) inhibitors
Kristin E. Rosner et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Tumor Necrosis Factor-α (TNF-α) Regulates Shedding of TNF-α Receptor 1 by the Metalloprotease-Disintegrin ADAM8: Evidence for a Protease-Regulated Feedback Loop in Neuroprotection
Joerg W. Bartsch et al.
JOURNAL OF NEUROSCIENCE (2010)
Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-α converting enzyme (TACE) inhibitors
Kaapjoo Park et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Discovery of novel spirocyclopropyl hydroxamate and carboxylate compounds as TACE inhibitors
Zhuyan Guo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
ADAM17 as a Therapeutic Target in Multiple Diseases
Joaquin Arribas et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8
Elmar Krieger et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2009)
Discovery of novel hydroxamates as highly potent tumor necrosis factor-α converting enzyme inhibitors. Part II: Optimization of the S3′ pocket
Robert D. Mazzola et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The ADAM metalloproteinases
Dylan R. Edwards et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
The ADAMs: signalling scissors in the tumour microenvironment
Gillian Murphy
NATURE REVIEWS CANCER (2008)
Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfones
Upul K. Bandarage et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Cutting edge:: TNF-α-cinverting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock
Keisuke Horiuchi et al.
JOURNAL OF IMMUNOLOGY (2007)
Identification of potent and selective TACE inhibitors via the S1 pocket
Jeffrey S. Condon et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
IK682, a tight binding inhibitor of TACE
Xiaoda Niu et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2006)
Flexible protein-protein docking
AM Bonvin
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
Stabilization of the autoproteolysis of TNF-alpha converting enzyme (TACE) results in a novel crystal form suitable for structure-based drug design studies
RN Ingram et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2006)
High-resolution protein-protein docking
JJ Gray
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates
JI Levin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates
JI Levin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules
A Ludwig et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2005)
Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases
S Xanthoulea et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for α-secretase activity in fibroblasts
D Hartmann et al.
HUMAN MOLECULAR GENETICS (2002)
Shedding of TNF-α receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus
JM Fernandez-Real et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
A continuous fluorimetric assay for tumor necrosis factor-α converting enzyme
GX Jin et al.
ANALYTICAL BIOCHEMISTRY (2002)
Peptide exosite inhibitors of factor VIIa as anticoagulants
MS Dennis et al.
NATURE (2000)
Share Paper
